Keywords: update, mgi, pharma, makes, 178m, bid, guilford

UPDATE: MGI Pharma makes $178M bid for Guilford, plus assuming $69.4M convertible debt

Article | 01 August 2005

Further consolidation of US mid-sized drug companies is forthcoming, with the proposed acquisition of Guilford Pharmaceuticals by MGI Pharma. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Guilford Pharmaceuticals

MGI Pharma

Go to company listing

Related Drugs

Aloxi

Palonosetron hydrochloride

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing